Results 151 to 160 of about 54,702 (261)

Association between proton pump inhibitor use and muscle mass: a US population-based study. [PDF]

Aging Clin Exp Res
Xiong G, Li L, Zhong H, Chen C, Ma L, Liang C, Liang M, He Y.   +7 more
europepmc   +1 more source

A Compact Hollow Fiber Electrode Assembly Architecture for Continuous Electrochemical Marine Carbon Dioxide Removal

Advanced Energy Materials, EarlyView.
A coaxial, membrane‐integrated hollow fiber electrode assembly (HFEA) is developed for continuous marine carbon mineralization. By utilizing a sub‐millimeter inter‐electrode gap, the HFEA minimizes Ohmic losses, achieving 50% energy reduction and over 85% DIC removal.
Inhwan Park, Young Hun Lee, Jung Hun Lee, Seung‐Jeong Oh, T. Alan Hatton, Dong‐Yeun Koh   +5 more
wiley   +1 more source

A High‐Voltage Membrane‐Free Li–Organic Hybrid Flow Battery Using Eutectic Lithium Chemistry

Angewandte Chemie, EarlyView.
A high‐voltage (3.6 V) membrane‐free Li–organic hybrid flow battery is enabled by a deep‐eutectic lithium electrolyte composed of trifluoroacetamide (TFAD) and LiPF6, paired with a dichloromethane (DCM) catholyte containing phenothiazine (PTZ). The TFAD/LiPF6 eutectic provides fast Li+ transport and stable Li‐metal cycling, while the immiscible TFAD ...
Xiao Wang, Bindu Dahal, Yuhang Tang, Jack J. McGrath, Rabin Siwakoti, Feng Wang, Jun Cheng, Jianbing “Jimmy” Jiang   +7 more
wiley   +2 more sources

Proton Pump Inhibitor Safety Knowledge and Stress Ulcer Prophylaxis Appropriateness Among Resident Physicians: A Cross-Sectional Study. [PDF]

J Multidiscip Healthc
Alfayez OM, Alkhezi OS.
europepmc   +1 more source

Natural Aging of Biomaterials in Ambient and Physiological Environments

Advanced NanoBiomed Research, EarlyView.
Biomaterials used in biomedical applications can change their physical properties over time, even under ambient and physiological conditions. This review highlights key studies on the natural aging of materials ranging from soft hydrogels to metals and ceramics, emphasizing how time‐dependent changes influence function and performance.
Shuyu Zhang, Anne E. Staples
wiley   +1 more source

Cerebellar Syndrome From Proton Pump Inhibitor-Induced Hypomagnesemia: Two Reversible but Relapsing Cases. [PDF]

Case Rep Otolaryngol
Léonard V, Gevers B, Van Damme JP, Garin P, Hardy M.   +4 more
europepmc   +1 more source

Proton-pump inhibitor exposure and prevalence of colorectal adenoma: a retrospective analysis from the Sakkopi study. [PDF]

BMJ Open Gastroenterol
Hofer H, Wernly S, Völkerer A, Semmler G, Flamm M, Hauptmann L, Wernly B, Aigner E, Datz C.   +8 more
europepmc   +1 more source

Trends, utilisation and appropriateness of proton pump inhibitor prescriptions among recent initiators: a decade-long analysis of patients with a 1-year washout period (2013-2021). [PDF]

BMJ Open
Liu Y, Zhang N, Ren W, Wang S, Xiang M.
europepmc   +1 more source

Cobblestone-like Gastric Mucosal Changes on Endoscopy in Dogs with a History of Prolonged Proton Pump Inhibitor Therapy. [PDF]

Animals (Basel)
Didier MD, Zagnoli L, Cattaneo D, Benali SL, Bottero E.   +4 more
europepmc   +1 more source

Letter to the editor regarding: "influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease". [PDF]

Ann Med
Gong Q, Jin R.
europepmc   +1 more source